Results 141 to 150 of about 6,976 (207)

Viral kinetics in adults with Covid-19 treated with nirmatrelvir-ritonavir or molnupiravir: a population-based, observational cohort study. [PDF]

Virol J
Prager M, Ensle D, Eser H, Glötzl F, Riedl B, Szell M, Valipour A, Zoufaly A, Wenisch C, Haider D, Burgmann H, Thalhammer F, Götzinger F, Jilma B, Karnthaler U, Zeitlinger M, Jorda A.   +16 more
europepmc   +1 more source

Molnupiravir for COVID-19

, 2022
openaire   +1 more source

Clarifications in JAMA Clinical Guidelines Synopsis.

JAMA
europepmc   +1 more source

Human liver-derived organoids recapitulate Oropouche virus infection and manifestation, enabling antiviral drug discovery. [PDF]

Cell Rep Med
Li J, Wang X, Ding Y, Qin F, de Lima STS, Papamichail L, Schraauwen R, Forato J, Claro IM, Hua X, Simões Mello LM, Offermans DM, Verstegen MMA, Boter M, Peppelenbosch MP, Barbiero A, Pagani E, Janssen HLA, Telmos Silva JA, Dos Santos MNN, Pincinato EC, Proenca-Modena JL, Li P, Anas AA, van der Laan LJW, Castilletti C, Oude Munnink BB, de Souza WM, Wang W, Pan Q.   +29 more
europepmc   +1 more source

Combination Therapeutic Effect of Antibacterial and Antiviral Agents on Feline Chronic Gingivostomatitis Nonbounded to Prior Tooth Extraction Confirmed by Physical Signs and Clinical Biomarkers. [PDF]

Vet Sci
Katayama M, Uemura Y.
europepmc   +1 more source

Prognostic factors in the selection of antivirals for COVID-19 in high-risk outpatients: A retrospective cohort study. [PDF]

Ther Adv Infect Dis
Bunditwongpaisan P, Chavapradit N.
europepmc   +1 more source

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Xiong X, Chen Z, Yan B.
europepmc   +1 more source

Antiviral Candidates and Vaccine Development for the Neglected Oropouche Virus. [PDF]

Viruses
Soares VC, Dias SSG.
europepmc   +1 more source

Hyperglycemia in Cats Infected by SARS-CoV-2: Pancreatic Alterations and Potential Antiviral Therapeutics. [PDF]

Microorganisms
Onodera T, Seo S, Sakudo A, Toniolo A.
europepmc   +1 more source

Designing Novel Compound Candidates Against SARS-CoV-2 Using Generative Deep Neural Networks and Cheminformatics. [PDF]

Int J Mol Sci
Li SY, Hung CM, Hung HY, Lai CW, Lee MC.
europepmc   +1 more source